LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 68.37 | 27.76 | 7090 | 6879 | 1.0306 | 1.0076 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 68.37 | 27.76 | 1274 | 6879 | 0.1852 | 0.6179 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 68.37 | 27.76 | 9953 | 6879 | 1.4468 | 1.0951 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.08 | 27.76 | 7141 | 6849 | 1.0425 | 1.0105 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.08 | 27.76 | 7256 | 6849 | 1.0593 | 1.0146 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.08 | 27.76 | 1324 | 6849 | 0.1933 | 0.6263 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.08 | 27.76 | 10170 | 6849 | 1.4847 | 1.1020 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.78 | 27.76 | 7331 | 6893 | 1.0635 | 1.0155 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.78 | 27.76 | 7500 | 6893 | 1.0880 | 1.0213 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.78 | 27.76 | 1226 | 6893 | 0.1779 | 0.6098 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.78 | 27.76 | 10373 | 6893 | 1.5048 | 1.1054 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.48 | 27.76 | 7487 | 6957 | 1.0761 | 1.0185 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.48 | 27.76 | 7640 | 6957 | 1.0981 | 1.0236 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.48 | 27.76 | 1366 | 6957 | 0.1963 | 0.6305 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.48 | 27.76 | 10584 | 6957 | 1.5212 | 1.1081 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 75.19 | 27.76 | 7624 | 7015 | 1.0868 | 1.0210 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 75.19 | 27.76 | 7826 | 7015 | 1.1156 | 1.0276 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 75.19 | 27.76 | 1347 | 7015 | 0.1920 | 0.6264 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 75.19 | 27.76 | 10765 | 7015 | 1.5345 | 1.1102 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.89 | 27.76 | 7702 | 7025 | 1.0963 | 1.0232 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.89 | 27.76 | 7931 | 7025 | 1.1289 | 1.0306 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.89 | 27.76 | 1244 | 7025 | 0.1771 | 0.6101 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.89 | 27.76 | 10910 | 7025 | 1.5530 | 1.1134 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.60 | 27.76 | 7696 | 7045 | 1.0923 | 1.0222 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.60 | 27.76 | 8054 | 7045 | 1.1431 | 1.0338 | MN20160318_Q01 | D09 |